FDA Inspection 1178933 — Atrium Medical Corporation

Atrium Medical Corporation — FEI 3011175548

The FDA completed an inspection of Atrium Medical Corporation on September 6, 2022 in Merrimack, NH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 6, 2022
Fiscal Year
2022
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Merrimack, NH (United States)